Abstract
We thank Thomopoulos and Tsioufis1 for their interest in our article2 and also for their positive feedback and criticism. We will try to answer directly to the 3 points raised in their letter. First, we would like to clarify our analyses regarding treatment posology. Although, in the protocol of the Spanish Ambulatory Blood Pressure Monitoring Registry, details of treatment posology were collected on a 3-category scheme, results from this cohort of patients with resistant hypertension indicated that only 41 patients (0.5% of the cohort) received part of their …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
